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Introduction 
Stroke- an all-inclusive term for acute failure of cerebrovascular circulation- is a 
leading cause of death in humans. When considered separately from other cardiovascular 
diseases, stroke ranks as the third leading cause of death, behind diseases of the heart and 
cancer (Center for Disease Control). In the United States, each year about 600,000 people 
suffer a new or recurrent stroke. About 500,000 of these are first attacks, and 100,000 are 
recurrent attacks. (Framingham Heart Study). Stroke is also a leading cause of serious, long-
term disability in the United States, affecting about 4,500,000 stroke survivors (2,200,000 
males and 2,300,000 females) who are alive today. 
The morbidity and thus the importance of stroke in the pediatric age group (<14 years 
old) seems to be minor: about 0.002-0.003% of children undergo some sort of global or focal 
hypoxic-ischemic insult or intracranial hemorrhage, and mortality is much less (Roach, 1993). 
However, during the perinatal period morbidity is approximately 0.05-0.1%, and may affect 
as much as 20-30% of premature infants (<35 gestational weeks) (Allan, 1990). Thus, 
neonatal stroke probably affects several million newborns worldwide. Neonatal stroke may 
result in severe, life-long neurological dysfunction that has an immense impact on both the 
health care system and the families providing care for such disabled children. In Germany 
alone, conservative estimates of cost of care to these children exceed 1 billion German 
marks/year (Berger and Gamier, 1999). Therefore, development of reasonable and successful 
therapies to diminish neural damage following stroke in newborns is of great importance. 
Compared to adult-onset stroke, there are some unique aspects that can be utilized in the 
therapy of neonatal stroke. First, in developed countries, virtually all babies are delivered in 
hospitals and may have instant access to adequate medical care in case of stroke. Second, 
babies at risk may be identified before the actual insult occurs, thus a low-risk effective 
pretreatment may prevent damage from a subsequent stroke. Third, the central nervous 
system of the newborn has a considerably larger plasticity compared to adults; a successful 
therapy reducing tissue damage may offer better functional recovery. 
Transient cerebral ischemia/reperfusion (I/R) induces neuronal injury both via 
insufficient cerebral blood flow (CBF) during the ischemic phase and reperfusion injury in the 
postischemic phase. Among the pathophysiological processes triggered by I/R, impaired 
cerebrovascular reactivity appears to play a significant role. Inadequate CBF regulation after 
I/R may worsen metabolic challenges of already compromised cells establishing a vicious 
circle. Therefore, preservation of cerebrovascular responsiveness after I/R is a promising area 
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of research to develop treatments that may complement other neuroprotective treatments 
(Hossmann, 1997). To obtain such strategies, we need to answer fundamental questions 
concerning the regulation of neonatal cerebrovascular circulation under physiological and 
pathophysiological conditions. 
Overview of the cerebral circulation in the neonate 
Total CBF in the neonate similarly to adults is determined primarily by two factors: 
(1) perfusion pressure, and (2) cerebrovascular resistance. Perfusion pressure is the difference 
between mean arterial pressure and mean venous pressure. Although perfusion pressure does 
not fluctuate significantly under physiological conditions, CBF is in fact very well maintained 
over a wide perfusion pressure range by a directly proportional change in vascular resistance. 
This feature of the cerebral circulation called cerebral autoregulation is present in both adults 
and neonates. The presence of autoregulation in neonates however, appears to be dependent 
on gestational age, and may be abolished by perinatal asphyxia (Younkin et al., 1987; Lou, 
1988; Pryds et al., 1990). Clinical and ethical concerns however, limit the study of 
autoregulation in human babies. Studies in experimental neonatal animal models like in 
newborn piglets, lambs, and puppies revealed that significant differences exist between the 
regulatory mechanisms of newborns and adults. The plateau phase of the perfusion pressure-
CBF relationship is shifted to the left, newborn animals for instance can maintain adequate 
CBF when arterial pressure is as low as 30-35 mmHg in contrast to 60-65 mmHg in adults 
(Ashwal et al., 1984; Leffler et al., 1986; Pasternak and Groothuis, 1985). 
Cerebrovascular resistance is determined by the factors described by Poisseuille's law: 
(1) blood viscosity, and (2) vascular geometry including number, length, and caliber of 
vessels. Indeed, vascular radius has the biggest impact on vascular resistance given that 
resistance is inversely proportional to 4th power of vascular radius, and this is the only 
regulated factor under physiological conditions. Conceivably, microvessels, especially pial 
and intracerebral arterioles are expected to contribute to the greatest extent to cerebrovascular 
resistance, due to their small diameters and relatively small numbers. Experimental data on 
the contribution of different vascular segments are scarce, but they indicate a significant 
involvement of large cerebral arteries in the regulation of cerebrovascular resistance (Heistad 
and Kontos, 1979). Studies in cats revealed that approximately 40% of total cerebrovascular 
resistance derives from arteries larger than 250-400 pm, and 60% of total resistance is 
contributed by pial and intraparenchymal arterioles (Faraci et al., 1987). Vascular diameter is 
actively determined by the tone of vascular smooth muscle (VSM). Therefore, the regulation 
of CBF simply depends on the combined effect of all vasodilator and vasoconstrictor stimuli 
on the VSM. Most of these stimuli are of chemical nature, and released from different 
cellular origin: neurons, glia, endothelial cells, perivascular nerve endings, and the VSM cells 
themselves. In addition to the vasoactive substances, VSM tone is also influenced by 
mechanical stretch, as well as electrical stimuli that can travel between the individual VSM 
cells through gap junctions. Unfortunately, not only the seemingly endless list of vasoactive 
substances but also the complex interactions between the regulatory cells and humoral 
mechanisms are responsible for the failure to provide undisputed in vivo evidence on the 
physiological role to most mechanisms. Limited studies in humans clarified the existence of 
basic cerebrovascular responses, but most systematic studies were carried out in animal 
models. These studies concluded, that many if not all cerebrovascular responses appear to be 
dependent on the species, the brain region studied, and clearly also on the brain 
developmental stage of the individual. These developmental differences can be of several 
qualities. First, some stimuli may differ in the amplitude of their effects on the cerebral 
circulation. For instance, stimulation of Sympathetic adrenergic nerves results in large 
decreases in CBF in newborn piglets (Busija et al., 1985; Wagerle et al., 1986), but only 
minor changes in adult pigs (Lee and al., 1981). Second, many stimuli evoke similar changes 
in brain perfusion in both adults and neonates, albeit via different mechanisms. A very good 
example is the special role that prostaglandins and thromboxanes (prostanoids) play in the 
cerebrovascular response to various stimuli. Prostanoids mediate vasodilation to hypotension 
(Leffler et al., 1986; Leffler and Busija 1987), and have permissive effect on the vasodilation 
to hypercapnia in piglets (Leffler et al., 1993,1994a, 1994b). In adult animals of many 
species these mechanisms are independent of prostanoids (Traystman, 1997). Third, some 
stimuli may elicit the opposite effect in newborns compared to adults. One striking example 
that acethylcholine induces vasoconstriction of the pial arterioles in piglets via prostanoids in 
contrast to the usual vasorelaxation seen in adults (Wagerle and Busija, 1989,1990). 
For over one hundred years maybe the most captivating hypothesis on the regulation 
of CBF that the brain is able to match its energy supply to meet the metabolic needs required 
by its local activity via corresponding changes in regional CBF (rCBF) (Roy and Sherrington, 
1890). This "neurovascular coupling" is now widely utilized in different functional neural 
imaging techniques, and became a major method to study the function of the human brain. In 
fact, positron emission tomography and functionajkgagfrotm resonance imaging demonstrate 
not the increase in activity but rather the increai&in metabolism and/or rCBF, by measuring 
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glucose utilization and oxygen consumption. (Phelps et al., 1979; Frackowiak et al., 1980) or 
the degree of hemoglobin oxygenation (Ogawa et al., 1992), respectively both in humans and 
laboratory animals. Therefore the use of these techniques relies on the tight and fast coupling 
between neuronal activity-induced increase in cerebral metabolism and rCBF. Tight CBF-
metabolism coupling has clinical relevance in stroke pathophysiology, since it prevents not 
only relative ischemia in activated regions but also luxury perfusion in regions of decreasing 
activation. Overperfusion may elevate tissue PaC>2 that could elicit oxidative damage of 
proteins and lipid membranes. Brain ischemia seems to uncouple CBF from metabolism, and 
may result in relative ischemic and/or overperfused areas during reperfusion (Kogure et al., 
1980). Either of these derangements may elicit further neuronal damage. 
Despite its significance, there is no equivocal understanding of this remarkable 
phenomenon. Neuronal activity may be signaled to cerebral resistance vessels by a number of 
possibilities. Neurons release a variety of substances upon activation including potassium 
ions, cellular metabolites and neurotransmitters. These substances may directly affect 
vascular smooth muscle, but may also induce release of specific vasoactive agents from other 
neurons, glia, and autonomic or sensory nerve endings. Actually, there may be no single 
mechanism to be identified. From this confusing variety the present paper focuses at one 
major possible local regulatory mechanism: the effect of excitatory amino acids on the 
regulation of CBF. 
The mechanism of NMDA-induced pial arteriolar vasodilation 
Excitatory amino acids glutamate and aspartate are the most common excitatory 
transmitters in the mammalian brain. In addition to their well-known transmitter role, 
glutamate and aspartate may participate in the mediation of CBF increases in response to 
neuronal activation. This hypothesis has been based on the pilot experiments by Busija and 
Leffler (1989), who reported dose-dependent pial arteriolar vasodilation to topical glutamate 
application using intravital microscopy in neonatal pigs. However, later glutamate receptor 
stimulation was found to dilate cerebral vessels in all species studied including both newborn 
(piglet, sheep) (Northington et al., 1995), as well as adult (rat, rabbit,) animals (Faraci and 
Breese, 1993). The effect of glutamate is largely mediated by N-methyl-D-aspartate (NMDA) 
receptors (Meng et al., 1995) in piglets. These receptors can be selectively activated by the 
subtype-specific analogue NMDA thus more specific data on this system could be obtained. 
Since NMDA receptors are associated with a wide range of physiological and pathological 
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functions, a whole series of studies was undertaken to explore the mechanism of NMD A 
receptor-mediated vascular dilation, and the effect of hypoxia/ischemia (H/I) on this neuronal-
vascular phenomenon. 
Glutamate andNMDA elicit a marked, dose-dependent pial arteriolar vasodilation. 
Compared to glutamate, NMDA induces more consistent and larger vasodilation probably due 
to the smaller elimination by glia. NMDA-induced vasodilation may be repeated several 
times during a single experiment, the vascular responses are essentially identical both in 
amplitude and dynamics upon repeated NMDA application (Busija and Meng, 1993a). This 
result suggests that the NMDA doses used are not affecting neuronal excitability and there is 
no tachyphylaxis. This feature of the response also enabled us to use repeated measurement 
experimental design to assess the mechanism of the response with pharmacology or the effect 
of H/I on vascular reactivity to NMDA. 
The exact mechanism of NMDA-related vascular changes is still unclear in some 
details, but considerable evidence indicates a unique action, requiring complex interactions 
between neurons and cerebral blood vessels. Neurons must have a key role in NMDA-
induced vascular dilation since neither cerebral blood vessels nor glial cells express NMDA 
receptors (Beart et al., 1988; Morley et al. 1998). Accordingly, cerebral vessels ex situ are not 
responding to NMDA (Wendling et al., 1996). Our current hypothesis on the mechanism of 
NMDA-induced vasodilation includes: 1) Activation of neuronal NMDA receptors, 2) inflow 
of Na+ and Ca2+ ions resulting in membrane depolarisation and action potentials, 3) 
subsequent activation of nNOS positive neurons via unidentified monosynaptic or 
polysynaptic local neuronal connections, 4) activation of nNOS by increased intracellular 
Ca2+ levels, 5) release and diffusion of NO from the neuropil to the blood vessels, and 6) 
arteriolar dilation due to NO actions on vascular smooth muscle. This hypothesis is based on 
the following findings. 1) In the piglet, NMDA-induced pial vasodilation is sensitive to 
inhibition of nitric oxide (NO) synthesis by L-nitroarginine-methyl-esther, but also by 7-
nitroindazole, a selective inhibitor of neuronal NO synthase (nNOS) (Bari et al., 1996a). 2) 
Recently, we have been able to show that NMDA application resulted in significant increases 
of NO metabolites in the cerebrospinal fluid over the stimulated pial surface (unpublished 
data). 3) Double immunostaining indicated that NMDA receptor immunoreactive neurons 
were much more numerous than nNOS positive neurons in the piglet cerebral cortex (Bari et 
al., 1998a). Further, nNOS and NMDA receptors do not seem to coexist in the same neurons. 
4) Tetrodotoxin suppresses NMDA-induced vasodilation (Faraci and Breese, 1993; Yang and 
Chang, 1998), also indicative that NMDA receptor positive neurons are different from those 
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releasing the NO upon NMDA application. Finally, 5) other possible vasodilator mechanisms 
have been tested with negative results: inhibition of endothelial function, prostanoid and 
epoxyeicosatrienoic acid (EET) biosynthesis did not alter NMDA-induced vasodilation 
(Busija and Leffler, 1989; our unpublished observations). 
Unfortunately, unambiguous data on the physiological relevance in the CBF-
metabolism coupling of this complex sequence are lacking. In anesthetized piglets, 
pharmacological blockade of NMDA receptors by MK801 does not affect pial arteriolar 
diameters (Meng et al., 1995). However, physiological glutamate-mediated vasoregulation 
may be more pronounced in the close vicinity of neurons than on distant arterioles of the pial 
surface. Indeed, decreases in baseline intraparenchymal vessel diameters have been reported 
after NMDA receptor inhibition in the hippocampus (Fargus and Lee, 1997). Several studies 
supported the involvement of NMDA receptors in the regulation of CBF. For instance, 
NMDA-receptor inhibition prevented nociceptive stimulation-induced increases in rCBF in 
the trigeminal nucleus in cats (Goadsby and Classey, 2000). Also, in a focal cerebral 
ischemia model in rats, MK801 was shown to decrease CBF by 30% in the unaffected 
hemisphere, however, MK801 did not affect CBF on the ischemic side (Park et al., 1989). 
There is an important limitation in the interpretation of such results. Namely, direct inhibition 
of NMDA receptors will also likely to alter neuronal activity per se. In addition, one can 
speculate that NMDA-induced vasodilation may be rather involved in the dynamic changes of 
CBF related to local activity changes that are largely suppressed during anesthesia. 
Fortunately, a recent PET study yielded compelling evidence suggesting the importance of 
NMDA receptors in the neuronal activity — rCBF coupling in conscious rhesus monkeys 
(Tsukada et al., 1998). In that study, D-cycloserin - a partial agonist of the strychnine-
insensitive glycine site of the NMDA receptor- significantly recovered the rCBF increase in 
the somatosensory cortex to vibrotactile stimulation abolished by scopolamine, without 
affecting neuronal activity. In conclusion, NMDA receptor activity appears to affect activity-
dependent CBF changes either directly via neuronal NO release or increased metabolism 
resulting in increased rCBF via a different albeit undisclosed metabolism-flow coupling 
mechanism. 
Effect of anoxic stress on cerebrovascular reactivity to NMDA 
The effect of different types of anoxic stress (hypoxia, ischemia, asphyxia) on 
cerebrovascular mechanisms to numerous stimuli has been extensively studied in piglets. In 
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general, selective impairment of some specific vasodilatory but not vasoconstrictor 
mechanisms was reported. More specifically, 20 min of global cerebral ischemia followed by 
2h reperfusion virtually abolished pial arteriolar dilation to hypercapnia, reversed vasodilation 
to vasoconstriction to arterial hypotension, but had no effect on vasodilation evoked by P G E 2 , 
and isoproterenol or vasoconstriction by norepinephrin (Leffler et al., 1989a-1989b-1989c). 
This duration of ischemia, however, is almost certainly too long to be clinically relevant, in 
fact piglets underwent to 20 min of global cerebral ischemia have never regained 
consciousness up to 24h post ischemia (Leffler et al., 1989a). Therefore, later studies used 10 
min global cerebral ischemia to study the short-term effect of I/R on pial arteriolar reactivity. 
This duration also attenuated hypercapnia-induced pial arteriolar vasodilation, but 
cerebrovascular reactivity gradually recovered within 2-4 hours after ischemia (Bari et al., 
1998b). Similar attenuation of cerebrovascular reactivity was observed with calcitonin gene-
related peptide (CGRP) (Louis et al., 1996), iloprost a stable prostacyclin analogue, and ATP-
sensitive potassium channel (KATP) opener aprikalim (Bari et al., 1996c). Interestingly, 
oxytocin-induced vasodilation was found to be reversed to constriction by I/R indicating that 
I/R preferentially targets dilator mechanisms (Bari et al., 1997a). However, 10 min ischemia 
did not affect pial arteriolar responses to many dilator agents such as arterial hypoxia, 
adenosine (Bari et al., 1998b), and NO donor sodium nitroprusside (SNP) (Busija et al., 
1996a). 
NMDA-induced vasodilation was demonstrated to be very sensitive to anoxic stress. 
During arterial hypoxia NMDA-induced vasodilation is diminished (Bari et al., 1998a), at 
least in part because oxygen is a substrate for NO synthesis. However, reoxygenation does 
not restore normal responsiveness to NMDA. Not only 10 min of asphyxia (Busija and 
Meng, 1993a) or global cerebral ischemia (Busija et al., 1996a) but also short periods (5 min) 
of hypoxia (Bari et al., 1996b) attenuate NMDA-induced vasodilation for 1-2 hours, then 
cerebrovascular reactivity gradually returns in 2-4 hours. Disturbed oxygen availability but 
not hypercapnia and acidosis seem to play major role in the pathogenesis of decreased 
arteriolar responses to NMDA after hypoxia. The impaired vascular response is related to the 
severity of anoxic stress. 15 min of hypoxia has a greater effect than 5 min hypoxia in 
attenuating the NMDA-induced vascular sequence (Bari et al., 1996b). However, 
hypercapnia resulting in severe respiratory acidosis does not affect vascular responses to 
NMDA. Several studies elucidated that the attenuation of NMDA-induced vasodilation after 
anoxic stress cannot be attributed to general deterioration of neuronal and vascular function, 
but rather due to the selective damage to NMDA receptor containing neurons, or the NMDA 
8 
receptors themselves. This hypothesis is based mainly on the following findings. 1) Pial 
arterioles show normal dilations to exogenous NO but not to NMDA after I/R indicating that 
VSM function remains intact. 2) Cortical nNOS enzyme levels and activity do not change 
after H/I (Beasley et al., 1998; Busija et al., 1996). 3) Kainate also activates neuronal 
glutamate (kainate) receptors; actions of both NO and prostanoids mediate the vasodilation 
(Bari et al., 1997b). This sequence is very similar to that of NMDA. However, kainate-
induced vasodilation is independent of activation of NMDA receptors. Further, kainate-
induced vasodilation is not affected by I/R (Bari et al., 1997b), indicating that not all 
neuronal-vascular response is damaged by H/I. Finally, 4) the assumption that the attenuation 
of NMDA-induced vascular dilation after H/I is due to a decrease in the number of functional 
NMDA receptors is also corroborated by the findings that upregulation of NMDA receptors 
results in an enhancement of NMDA-induced increases in CBF without affecting basal CBF 
(Weiss et al., 1996). 
Role of reactive oxygen species (ROS) in the attenuation of NMDA-induced vasodilation 
after anoxic stress 
The pathomechanism of decreased neuronal-vascular responsiveness to NMDA after 
H/I is only partly understood. All available evidence indicates the involvement of ROS in the 
attenuation of NMDA-induced vasodilation after H/I. This notion is supported mostly by 
experiments where different pharmacological interventions preserved the cerebrovascular 
responsiveness to NMDA. Thus, local treatment with superoxide dismutase (SOD) during 
hypoxia and reoxygenation (Bari et al., 1996b), or systemic pretreatment with oxypurinol 
prior to asphyxia (Busija and Meng, 1993a) preserved NMDA-induced vasodilation by 
scavenging ROS produced in the reoxygenation/reventilation period. Importantly, these 
studies also found NMDA-induced vasodilation unaltered when the piglets were pretreated 
with cyclooxygenase (COX) inhibitor indomethacin prior the anoxic stress. COX has been 
demonstrated be the major source of superoxide anions both after hypoxic hypoxia, 
asphyxia/reventilation and global cerebral ischemia/reperfusion in the piglet (McGowan et al., 
1994; Pourcyrous et al., 1993; Armstead et al., 1988). In the latter study, indomethacin was 
able to suppress SOD-inhibitable nitroblue tetrazolium reduction to similar extent as the 
radical scavenger oxypurinol. During H/I, arachidonic acid (AA) is released by activated 
phospholipases (Abe et al., 1987; Umemura et al., 1992), but further metabolism is inhibited 
by the lack of oxygen shown by unaltered superoxide production during anoxia (Pourcyrous 
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et al., 1993). In contrast, reoxygenation results in excessive AA metabolism by COX that 
produces PGH2 and superoxide anions in an equimolar concentration. The superoxide 
production in this uncontrolled reaction may exceed the antioxidant capacity and result in 
oxidative damage to membrane lipids and proteins including the NMDA receptor itself 
(Graham et al., 1996; Marro et al., 1998). In addition to NMDA, other ischemia-sensitive 
vascular mechanisms could also be preserved by inhibiting ROS production by indomethacin, 
such as pial arteriolar dilation to CGRP (Louis et al., 1996), prostacyclin, and K A T P channel 
opener aprikalim (Bari et al., 1996c). Not only microvascular reactivity, but also altered 
blood-brain barrier transport by I/R can be preserved with indomethacin (Zuckerman et al., 
1994) similarly to SOD and catalase (Armstead et al., 1992), indicating an overall effect of 
COX-produced ROS on microvascular pathology elicited by anoxic stress. In summary, 
ROS, especially COX-derived superoxide radicals seem to play a major role in the attenuation 
of NMDA-induced vasodilation. 
Ligand-gated potassium channels in the brain and the cerebral circulation 
Recently considerable attention has been focused at potassium channels of neurons 
and cerebral vessels for at least three different reasons: (1) potassium conductance determined 
by potassium channels have a major influence on VSM tone, and a number of vasoactive 
stimuli were shown to mediate their effect via potassium channels; (2) neuronal potassium 
channels affect cell excitability, calcium homeostasis and neurotransmitter release through 
their effect on membrane potential, and all these factors may be crucial in survival of neurons 
after anoxic stress; and (3) K A j p have been shown to be involved in the mechanism of 
ischemic preconditioning (PC) in the myocardium. P C is a phenomenon whereby exposure 
to a brief ischemic period protects the cells from the damage inflicted by a subsequent longer 
anoxic stress. P C can be induced in the brain by global cerebral ischemia (Kitagawa et al., 
1990), and various other stimuli (Prass et al., 1998), but the potential involvement of K A j p 
channels in the development of neuronal P C is not known. 
In the VSM of cerebral vessels four different classes of potassium channels have been 
found: (1) Ca2+-sensitive (K^a), (2) K A T P , (3) voltage-gated delayed rectifier, and (4) 
inwardly rectifying potassium channels (Faraci and Sobey, 1998). Activation of these 
channels results in increased potassium conductance with subsequent outward potassium 
current down the electrochemical gradient of potassium resulting in hyperpolarization. Since 
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the estimated "resting" membrane potential of cerebral VSM cells is about -36-46 mV and 
the equilibrium potential for potassium measures around -85 mV, little changes in potassium 
conductance change VSM membrane potential significantly. Changes in VSM membrane 
potential are determining free intracellular Ca2+ levels via affecting the activity of voltage-
gated Ca2+-channels thus regulating VSM contraction. The most numerous potassium 
channels in VSM are believed to be the channels estimated around 104 channels present 
per cell (Nelson and Quayle, 1995). These channels are activated by increases in intracellular 
Ca2+. One important physiological function of these channels to limit vasoconstriction 
elicited by increased Ca2+ levels originating from either extra- or intracellular sources. The 
role of KQ, channels in the regulation of pial arteriolar caliber has been investigated in piglets 
(Ban et al. 1997c). Selective activation of Kc a channels with NS1619 produces dose-
dependent vasodilation. However, selective inhibition of Kc a channels by charybdotoxin 
does not affect baseline arteriolar diameters indicating that these channels are quiescent at rest 
similarly to other microvascular beds (Jackson and Blair, 1998). Nevertheless, charybdotoxin 
does inhibit vascular dilation to activators of adenylate cyclase, and cAMP analogues. 
Importantly, channel activators successfully dilate pial arterioles lh after 10 min of 
global cerebral ischemia, thus this vasodilatory mechanisms may be utilized to dilate cerebral 
resistance vessels in an effort to increase brain perfusion after stroke (Bari et al., 1997c). KC a 
channels mediate vasodilation induced by ROS, and thus mechanism appears to play a role in 
the mechanism of reactive hyperemia in the reperfusion period (Sobey et al., 1997). 
Similarly to Kca> K A T P channels can also be found in cerebral microvessels albeit 
much fewer in numbers compared to K^a. A crucial feature of these channels that their 
activity may somewhat reflects the metabolic state of the cell: ATP inhibits channel activity. 
The K A T P channel activator aprikalim is a potent dilator of pial arterioles in piglets, but the 
selective inhibitor glibenclamide does not cause vasoconstriction, indicating that K A T P 
channels probably do not determine resting VSM tone (Bari et al., 1996c). However, pial 
arteriolar responses to various stimuli are sensitive to inhibition by glibenclamide. In piglets, 
K A T P Channels mediate CGRP and prostacyclin-induced arteriolar dilations. In contrast to 
Kca, KATP Channels were found to be vulnerable to ischemic stress, aprikalim, CGRP, and 
iloprost -induced vasodilation was severely inhibited up to 4 h after 10 min of global 
ischemia (Bari et al., 1996c; Louis et al., 1996). 
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All types of potassium channels, including KC a and K A T P channels have been 
identified also on neurons. However, the physiologic role of these channels on neuronal 
function is unclear. Activation of these channels by potassium channel openers (KCO-s) has 
produced neuronal hyperpolarization. Importantly, in some in vivo or in vitro experimental 
settings, KCO-s employed protective effects both on neuronal function and survival. Perhaps 
this effect may not be so surprising since KCO-induced neuronal hyperpolarization may 
prevent or delay the development of anoxic depolarization (AD). AD is characterized by the 
loss of transmembrane potential due to metabolic energy failure. The duration of AD 
correlates with the extent of hypoxic neuronal damage (Balestrino et al. 1989) indicating its 
importance in the development of neuronal injury after anoxic stress. AD may trigger several 
potentially neurotoxic events such as Na+ and Ca2+ loading, intracellular edema formation, 
together with subsequent glutamate release, ROS generation, and activation of the apoptotic 
cascade. Therefore, KCO-s may represent a class of potential neuroprotective agents that 
prevent uncontrolled ion fluxes in compromised neurons similarly to inhibitors of voltage-
gated sodium and calcium channels ad well as ionotropic glutamate receptor antagonists. 
KATP channels appear to play a key role in the antiischemic effect of IPC in the heart. 
The induction of IPC is a multi-step process involving redundant extracellular mediators, 
signal transduction mechanisms and complex intracellular cascade of kinases (Cohen et al., 
2000). Nevertheless, KATP-S probably serve as the final common pathway in the generation of 
IPC. KCO-s mimic IPC (Gross and Fryer, 1999; Liu et al., 1998; Garlid et al., 1997; Baines 
et al, 1999), and the protection by IPC is blocked by K A T P inhibitors in dogs (Auchampach et 
al., 1992; Gross and Auchampach, 1992) and pigs (Shulz et al., 1994). The exact mechanism 
of this remarkable effect has not been elucidated, but paradoxically sarcolemmal KATP 
channels may not participate (Liu et al., 1998). However, recent findings strongly indicate the 
involvement of mitochondrial KATP (mitoKATp) channels in the mediation of IPC in the heart. 
MitoKATp channels differ from the sarcolemmal ones in their pharmacological profile. 
M U O K A T P channels can be selectively activated with diazoxide (DIAZ), or inhibited with 5R 
hydroxy-decanoate (5-HD) (Garlid et al., 1996a, 1997). Indeed, DIAZ preserves post-
ischemic cardiac function and reduces infarct size in rabbits independently of sarcolemmal 
KATP channels (Liu et al., 1998). It is not clear why activation of mitoKATP channels is 
cardioprotective, or this antiischemic effect of mitoKATp channels would occur in the brain. 
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Neuroprotection by protein synthesis inhibitors 
Suppressed protein synthesis is a substantial feature of hypoxic neuronal damage 
(Hossmann, 1996a). Long-lasting inhibition of cellular protein synthesis may directly 
contribute to neuronal loss conceivably because injured cells are unable to repair their 
proteom. Also, the recovery of NMDA-induced vasodilation after H/I may involve 
replenishment of proteins damaged by ROS. Therefore, pharmacological inhibition of protein 
synthesis may delay the restoration of NMDA-induced vasodilation after H/I. Paradoxically, 
several studies provided evidence that protein synthesis inhibitors are beneficial when 
administered shortly before or after cerebral ischemia in different experimental conditions. 
For instance, postischemic administration of the translation inhibitor cycloheximide (CHX) 
prevented delayed neuronal cell death in the hippocampal CA1 region (Goto et al., 1990). 
This effect of CHX was attributed to the inhibition of apoptotic gene expression required for 
cell death. More interestingly, other studies showed that CHX pretreatment reduces infarct 
size in transient focal ischemia models in rats (Linnik et al., 1993; Du et al., 1996). In an 
elegant study, Aronowski et al. (1997) convincingly demonstrated that the neuroprotective 
effect of CHX was to preserve those brain areas that were lost to reperfusion injury. More 
specifically, transient focal ischemia evoked by middle cerebral artery (MCA) occlusion 
produced bigger infarcts than permanent MCA occlusion. However, after CHX 
administration transient ischemia resulted in same infarct size as seen after permanent MCA 
occlusion. The authors concluded that a short-lived transiently expressed noxious/killer 
protein would be responsible for the neuronal death in the areas of reperfusion injury that was 
blocked by CHX. 
Rationale of the present studies 
NMDA elicits a complex neuronal-vascular sequence that is severely attenuated by 
anoxic stress via ROS. We wanted to further investigate the pathomechanism of altered 
cerebrovascular reactivity to NMDA after I/R, since it is a likely factor in the physiological 
regulation of rCBF. In addition, pharmacological preservation of this response after I/R 
would indicate intact cerebrovascular responsiveness that directly or indirectly imply a 
neuroprotective action. Based on the findings described in the previous sections we wanted to 
test the following specific hypotheses: 
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1. We wanted to determine if depolarization of the cerebral cortex per se affects vascular 
responses to NMDA. Cortical depolarisation (CD) also occurs during anoxia as well as 
cortical spreading depression (CSD), a transient CD that is accompanied by tremendous 
increases in metabolism and CBF. Diminished cerebrovascular responses have been reported 
after single CSD-s even when cerebral oxygenation was unchallenged in cats and rats 
(Lauritzen et al., 1984; Wahl et al., 1987; Piper et al. 1991), but not in rabbits (Busija and 
Meng, 1993b). Moreover, CSD-like transient CD-s called periinfarct depolarizations were 
suggested to play a role in the developing neuronal injury after focal ischemia (Hossmann, 
1996b). Thus, we tested the hypothesis if CD induced by topical KC1 reduced NMDA-
induced vasodilation. 
2. We also addressed if pretreatment with potassium channel openers (KCO-s) such as 
aprikalim or NS1619 (activators of K A T P or K C A , respectively), and other vasodilators like 
CGRP, or papaverine prior to H/I preserved NMDA-induced vasodilation. 
3. The results from experiments described previously urged us to search for other targets of 
K C O - s than plasmolemmal potassium channels. We investigated if selective activation of 
mitochondrial K A T P channels by diazoxide (DIAZ) preserved the NMDA-induced vascular 
response after global ischemia. We also tested if DIAZ affected NMDA-induced vasodilation, 
and if the effect of DIAZ could be antagonized with 5-hydroxy-decanoate (5-HD). 
4. We assessed if transcription inhibitor Actinomycin-D (Act-D) and CFIX affected NMDA-
induced vasodilation. We then also explored whether Act-D and/or CHX pretreatment would 
preserve NMDA-induced vasodilation after ischemia. 
5. The protective effect of protein synthesis inhibitors on NMDA-induced vasodilation after 
ischemia was similar to cyclooxygenase inhibitors. Therefore, we tested if CHX had a short-
term effect on cortical COX-activity. Therefore, we tested if CHX affected COX-dependent 
pial arteriolar responses to hypercapnia and arterial hypotension, and cortical metabolism of 
exogenous AA. 
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Materials and methods 
The results of the papers related to the subject of this thesis have been derived from 
experiments on 183 piglets. For the sake of clarity and brevity, only those procedures as well 
as experimental groups and designs shall be described in detail that are crucial for the 
interpretation of results. The reader is referred to the original papers attached for any 
additional detail. 
The piglet as an experimental model 
The neonatal piglet is a widely accepted and popular model to study the cerebral circulation as 
well as the cardiorespiratory and endocrine systems (Book and Bustad, 1974). At birth, the 
size and brain developmental stage are similar to humans, and the physical development in 
the first 2 weeks parallels that of the first month of life of the human newborn ( De Roth and 
Downie, 1978). Concerning the cerebral circulation neonatal piglets feature remarkably 
similar cerebrovascular responses as compared to human babies (Busija, 1994). 
The closed cranial window technique 
Essentially all data in these studies were obtained using the closed cranial window technique 
and intravital microscopy described below. The history of this experimental approach dates 
back to the 1920-s, and Forbes (1928) published the first detailed description of the method. 
We have used the closed cranial window technique described previously by Levasseur et al. 
(1975) with slight adaptation to the neonatal piglet. This method has numerous advantages 
far outweighing the technical limitations in assessing the pial microcirculation in vivo. The 
observer is able to continuously observe the pial circulation. Changes in pial arteriolar 
diameter can be measured which vessel segment makes up a significant portion of total 
cerebral vascular resistance. However, it is important to note, that these vessels are not the 
only determinants of cerebrovascular conductance. Thus, vasodilation or vasoconstriction 
upstream or downstream affects flow through these pial vessels. In conclusion, pial arteriolar 
diameter measurements are excellent to study microvascular reactivity. Pial arteriolar 
diameter changes do relate but may not always exactly predict changes in CBF as described 
by Poiseuille's law. On the other hand, the 4th power relationship between vascular radius and 
blood flow may result in statistically undetectable changes in vascular diameter when changes 
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in CBF do not exceed 5-10% (cf. 1-3% changes in diameter). This relative "insensitivity" of 
the method is mainly due to the technical limitation of measurement accuracy, and 
considerable biological variability. Sealing and cementing "closing" the cranial window has 
further advantages: (1) the integrity of the skull thus normal intracranial pressure (ICP) is 
restored. (2) The space between the pial surface and the glass window may be filled with 
artificial cerebrospinal fluid (aCSF) providing physiological environment for the pial vessels 
observed. (3) It also allows application of drugs locally to the brain surface circumventing 
their systemic effects on cerebrovascular circulation, and aCSF samples can be collected to 
determine concentrations of endogenous vasoactive substances. (4) Finally, the mechanical 
stability of the surgical preparation enabled us to induce selective and well-controlled anoxic 
stress by producing global cerebral ischemia via elevated ICP. 
Animals 
Newborn piglets of either sex (1-7 days old, body weight 1-2 kg) were used. All 
procedures were approved by the Institution Animal Care and Use Committee. The animals 
were anesthetized with sodium thiopental (30-40 mg/kg ip) followed by intravenous injection 
of a-chloralose (75 mg/kg). Supplemental doses of a-chloralose were given to maintain a 
stable level of anesthesia. The right femoral artery and vein were catheterized to record blood 
pressure and to administer drugs and fluids, respectively. The piglets were intubated via 
tracheotomy and artificially ventilated with room air. The ventilation rate (~20/min) and tidal 
volume (~20 ml) were adjusted to maintain arterial blood gas values and pH in the 
physiological range. Body temperature was maintained at 37-38 °C by a water-circulating 
heating pad. Body temperature, arterial pH and blood gases were also in the normal ranges, 
and did not vary significantly among different groups. 
The head of the piglet was fixed in a stereotactic frame. The scalp was incised and 
removed along with the connective tissue over the calvaria. A circular (19 mm in diameter) 
craniotomy was made in the left parietal bone. The dura was cut and reflected over the skull. 
A stainless steel cranial window with three needle ports was placed into the craniotomy, 
sealed with bone wax and cemented with cyanoacrylate ester and dental acrylic. 
The closed window was filled with artificial cerebrospinal fluid (aCSF). warmed to 
37°C and equilibrated with 6% 0 2 and 6.5% C02 in balance N2 to give pH=7.33, pC02=46 
mmHg, and p02=43 mmHg. The aCSF consisted of (mmol/L): NaCl 132, KC12.9, CaCl21.2, 
MgCl21.4, NaHCCb 24.6, urea 6.7 and glucose 3.7.^Diambt^rs of pial arterioles were 
fa I \ 
( u O 
V 7 
16 
measured using a microscope (Wild M36, Switzerland) equipped with a video camera 
(Panasonic, Japan) and a video micro scaler (IV-550, For-A-Co. Newton, Mass., USA). At 
the end of the experiments the animals were killed while anesthetized with an intravenous 
bolus of 5% KC1. 
General protocol to study the effects of drugs and anoxic stress on NMDA-induced 
vasodilation 
These studies were based on the same principle (Figure 1.). We determined NMDA-induced 
vasodilation before, and 1-4 h after a physiologic, pharmacological or combined physiologic 
and pharmacological challenge. First, we obtained stable baseline arteriolar diameters, by 
gently flushing the cranial window with aCSF several times. We examined the responses of 
cerebral arterioles (baseline diameter - 1 0 0 pm) to different doses of NMD A (10, 50, 100 
pmol/L). The NMDA, and all other drugs were dissolved in aCSF and administered topically 
through the injectable ports of the cranial window onto the brain surface with single 
application unless otherwise stated. Arteriolar diameters were measured continuously for 5-7 
min for each dose of NMDA. Typically, maximal steady state vasodilation was observed 2-4 
min after NMDA application. Then the window was flushed with aCSF and the arteriolar 
diameters returned to baseline values. The same procedure has been repeated after the 
following stimuli. 
Cortical Depolarization 
CD was achieved by single topical application of lmol/L KC1 dissolved in aCSF for 3 
min. After CD the cranial window was infused several times with aCSF until arteriolar 
diameters returned to baseline. To demonstrate CD, in some animals extracellular DC 
potential was recorded. The DC potential was derived from the potential between a 
silver/silver-chloride electrode placed on the frontoparietal cortex 5 mm anterior to the cranial 
window and a grounded reference electrode placed in the subcutaneous connective tissue of 
the scalp, amplified (EXT-MC, Experimetria Ltd., Hungary), and stored with an on-line data 
acquisition software. 
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Combined cerebral hypoxia/ischemia (H/I) 
Cerebral hypoxia was induced by artificial ventilation with 8.5% O2 balance N2 over 10 min. 
Arterial blood gases were measured 8 min after hypoxia was started. After 10 min of hypoxia 
ventilation with room air was restored, but hypoxia immediately was followed by cerebral 
ischemia as described below. 
Global cerebral ischemia 
To induce global cerebral ischemia, a 3-mrn hole was made by an electric drill with a 
toothless bit, and the dura was exposed. A hollow brass bolt was inserted in the left frontal 
cranium rostral to the cranial window and secured in place with cyanoacrylate ester and dental 
acrylic. Cerebral ischemia was produced by infusion of aCSF to raise ICP above arterial 
pressure. Ischemia was verified by the cessation of blood flow in the observed vessels. 
Previously, using microspheres CBF was shown to be virtually zero (<lml/min/100g) in all 
brain areas examined during the ischemic period (Beasley et al., 1998). When this type of 
anoxia was induced in unanesthetized piglets, within 5 seconds all animals became 
unresponsive to tactile and auditory stimuli, and the pupils were fixed and dilated (Leffler et 
al., 1989a). Venous blood was withdrawn as necessary to overcome the Cushing response 
and maintain mean arterial blood pressure near normal values. At the end of the ischemic 
period the infusion tube was clamped and the ICP could return to preischemic values. The 
heparinized blood was reinfused intravenously. 
Experimental groups 
Group 1 (n=9): NMDA-induced vasodilation was assessed before and 1 hour after 3 min of 
CD. (Figure 1.) 
Groups 2-6 (n=7,6,7,6,5, respectively) NMDA-induced vasodilation was assessed before and 
1 h after combined H/I. Different groups received topical pretreatment of aCSF, NS1619 
(lOpmol/L), aprikalim (lpmol/L), calcitonin gene-related peptide (CGRP, lpmol/L), and 
papaverin (10 pmol/L), respectively for 10 min prior H/I. Arteriolar responses to these drags 
were recorded during this period. The drags were washed away just before the beginning of 
hypoxia. 
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Groups 7-11 (n=8,8,8,12,5) NMDA-induced vasodilation was assessed before and 1 h after 10 
min of global cerebral ischemia. Different groups received the following pretreatments: none, 
topical diazoxide (DIAZ, l,5,10pmol/L), and lOpmol/L DIAZ coapplied with the antagonist 
5-hydroxy decanoate (5-HD), respectively 
Groups 12-16 (n=7,5,5,5,5, respectively) NMDA-induced vasodilation was assessed before 
and 1, 2, and 4 h after 10 min of global cerebral ischemia. Different groups received the 
following pretreatment: none, topical Act-D (1,10 pmol/L) for 15 min washed away just 
before the onset of ischemia, and iv injection of CHX (0.3,1 mg/kg, dissolved in saline) given 
20 min prior to ischemia, respectively. 
Groups 17-18 (n=4,6) In these groups NMDA-induced vasodilation was assessed before and 1 
h after different drug treatments in the absence of anoxic stress. Group 17 received topical 
DIAZ (10pmol/L) for 10 min, Group 18 first topical Act-D (10pmol/L) for 15 min, and after 
that trial iv CHX (1 mg/kg), respectively. 
Groups 19-21 (n=22, not shown on Figure 1) Responses of cerebral arterioles to COX-
dependent (arterial hypercapnia, arterial hypotension), and COX-independent (SNP) stimuli 
were examined before and 20 min after CHX treatment. Different groups received iv vehicle, 
and CHX (0.3, lmg/kg) respectively. Hypercapnia was elicited by artificially ventilating the 
animal with a gas mixture containing (5% or 10% C02 ,21% 0 2 , balance N2). Arterial 
hypotension was induced by withdrawing venous blood to yield approximately 25% and 40% 
decreases in MAP, respectively. Following the measurements the heparinized blood was 
reinfused. SNP (1, 10 pmol/L) dissolved in aCSF was administered topically. Arteriolar 
diameters were measured continuously for 5 min for each stimulus, until steady state values 
were obtained. Typically, we obtained data for two different stimuli in each animal. With 
this protocol we obtained similar arteriolar responses to hypercapnia, hypotension, and SNP 
to previous experience with these challenges. These doses of hypercapnia, hypotension, and 
SNP were chosen to provide medium and large increases in vascular diameters. Between 
different stimuli the window was flushed with aCSF, and the arteriolar diameters returned to 
baseline values. Twenty min after treatment, challenges of hypercapnia, arterial hypotension 
and SNP were repeated according to the procedure described above. 
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Figure 1. Experimental protocols to study N-methyl-D-aspartate (NMDA)-induced 
vasodilation before and after various physiological and/or pharmacological manipulations 
using repeated measurement experimental design. Pial arteriolar vasodilation to NMD A (10-
100 pmol/L) was detected using closed cranial window/intravital microscopy before and l-4h 
after treatments. All drugs were applied topically onto the pial surface for lOmin, except 
cycloheximide (CHX) that was given intravenously 20 min before. CD: cortical 
depolarization (3min) by 1 mol/L KC1; H: 10 min hypoxia (ventilation with 8.5% 0 2 in N2); I: 
lOmin global ischemia by elevated intracranial pressure; NS1619: selective activator of Ca2+-
2 0 
sensitive potassium channels; APK: aprikalim, selective activator of ATP-sensitive potassium 
channels channels; CGRP: calcitonin gene-related peptide; 1-10DIAZ: diazoxide (1-10 
pmol/L), selective activator of mitochondrial ATP-sensitive potassium channels; 5HD/DIAZ: 
coapplication of 100 pmol/L 5-hydroxy-decanoate - selective inhibitor of mitochondrial ATP-
sensitive potassium channels - with 10 pmol/L diazoxide; 1-10 Act-D: 1-10 pmol/L 
Actinomycin-D, inhibitor of gene transcription; .3-1CHX: 0.3-1 mg/kg cycloheximide, 
inhibitor of protein translation. 
Group 22 (n=9) We determined cortical conversion of exogenous AA to PGF2ot and 6-keto-
PGFia. AA (1, 10, and 20 pg/ml) dissolved in aCSF was administered onto the brain surface 
through the injectable ports of the cranial window. Each dose of AA was applied on the brain 
surface for 10 min, then the cranial window was gently flushed and the effluent aCSF (-300 
pi) was collected and frozen. AA was applied with 1 hr intervals 2 times before, then 20 min 
and 1 hr after CHX (1 mg/kg, iv) treatment. Typically, we applied AA 3 times in each 
animal. Since the data obtained from these animals did not differ significantly, we combined 
these data as shown in the Results. From the aCSF samples concentrations of PGF2a and 6-
keto-PGFia were determined using ELISA kits (Oxford Biomedical Research Inc., Oxford, 
Mich., USA). 
Chemicals & Statistics 
The drugs used in these studies were: SIGMA: NMD A, DIAZ, papaverine, SNP, AA, 
CHX; Rhone-Roulenc-Rohrer: aprikalim; Research Biochemical International: NS1619, 
CGRP, 5-HD; and Calbiochem: Act-D. 
Data are expressed as mean ± standard error of the mean (SEM). Pial arteriolar 
diameter data (absolute and percent change) were analyzed using repeated measures analysis 
of variance (ANOVA). Percent preservations of preischemic vasodilation data between 
different experimental groups were analyzed using one-way ANOVA. For pairwise 
comparisons the Student-Newman-Keuls test was used where appropriate. P values of <0.05 
were considered as statistically significant. 
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Results 
Effect of CD on cerebrovascular reactivity to NMDA. 
In all animals topical application of lmol/L KC1 resulted in a large reduction of 
diameters of pial arterioles from 105±3 to 48±4 pm (n=27). Also, there was a negative 
deflection in the extracellular DC potential (max 5-7 mV) indicating CD. After 3 min the 
KC1 was washed out by repeated infusion of aCSF and arteriolar diameters returned to 
baseline within 30-40 min. 
In Group 1, NMDA resulted in a dose-dependent arteriolar vasodilation. The baseline 
diameters were very similar (102±2 versus 99±3 pm, before and after CD). Only at the 
highest dose the absolute change in diameter was slightly (-10%) decreased. However the 
percent changes were intact (9±1 versus 8±1 at 10 pmol/L, 19±2 versus 18±3 at 50 pmol/L, 
and 29±2 versus 26±3 at 100 pmol/L NMDA). Thus, prior CD did not significantly affect the 
NMDA-induced vasodilation. Similarly, CD did not affect other ischemia-sensitive 
mechanisms like pial arteriolar dilations to hypercapnia, CGRP, or aprikalim (data not shown, 
see details in Appendix I). 
Effect of anoxic stress on NMDA-induced vasodilation 
Global cerebral ischemia or combined H/I did not alter baseline arteriolar diameters 
significantly. However, both types of anoxic stress severely attenuated NMDA-induced 
vasodilation as previously reported. For instance, in Group 7 and in Group 12 10 min 
ischemia reduced vascular responses to 100 pmol/L NMDA by -50%, percent changes from 
baseline (before versus 1 h after ischemia) were 38±5% versus 16±4%, and 40±4% versus 
20±4%, respectively (see also Figure 2.). Combined H/I damaged NMDA-induced 
vasodilation even more; in Group 2 percent changes from baseline (before versus 1 h after 
H/I) to 100 pmol/L NMDA were 33±4% versus 1±2%. The attenuation of NMDA-induced 
vasodilation by ischemia was transient, arteriolar dilations to NMDA gradually returned in 4h 
after ischemia. In Group 12 percent changes from baseline (before versus 1, 2, and 4 h after 
ischemia) to 100 pmol/L NMDA were 40±4% versus 20±4%, 27±5%, and 34±5%, 
respectively. 
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Effects of KCO-s on pial arteriolar diameters 
Pretreatment with NS1619 and aprikalim elicited pial arteriolar vasodilation. Percent 
changes from baseline were 15±4% (Group 3), and 26±7% (Group 4). However, DIAZ did 
not affect pial vascular diameters significantly. Typically, there was only a transient dilation 
immediately upon application of DIAZ unlike the maintained dilation elicited by NS1619 or 
aprikalim. Percent changes from baseline diameters were: in Group 8, no vasoactivity was 
observed; in Group 9, 2±1%, in Group 10,9±3% but vascular diameters quickly returned to 
baseline values in 2-3 min, and none of these changes were significantly different from 
baseline values. 
Preservation of NMDA-induced vasodilation after anoxic stress by KCO-s 
The KCO-s used in these studies did not affect NMDA-induced vasodilation directly. 
For instance in Group 17,10 pmol/L DIAZ did not potentiate or attenuate vascular dilations 
to NMDA 1 hr after DIAZ treatment. Baseline arteriolar diameters were 100±2pm before and 
100±6pm 1 hr after DIAZ treatment. Percent changes in pial arteriolar diameter from 
baseline to 10, 50, and 100 pmol/L NMDA (before versus 1 hr after DIAZ treatment) were 
3±1% versus 4±1%, 28±7% versus 26±9%, and 50±8% versus 47±8%, respectively. In 
contrast, KCO-s preserved NMDA-induced vasodilation lh after anoxic stress. 
In Group 3 (NS1619)-, baseline arteriolar diameters were 103±3pm before and 
104±3pm 1 h after H/I. Percent changes in pial arteriolar diameter from baseline to 10, 50, 
and 100 pmoI/L NMDA (before versus 1 h after H/I) were 9±2% versus 6±4%, 19±6% versus 
21±5%, and 35±3% versus 31±5%, respectively. 
In Group 4 (aprikalim), baseline arteriolar diameters were 101±4pm before and 
104±4pm 1 h after ischemia. Percent changes in pial arteriolar diameter from baseline to 10, 
50, and 100 pmol/L NMDA (before versus 1 h after H/I) were 6±2% versus 8±2%, 22±6% 
versus 15±3%, and 41±5 versus 32±6%, respectively. 
DIAZ also employed dose-dependent effect on preservation of NMDA-induced 
vasodilation after ischemia. In Group 8(1 pmol/L DIAZ), decreases in pial arterial 
responsiveness to NMDA were similar to those observed in Group 7. In Group 8, baseline 
arteriolar diameters were 102±3pm before and 104±3pm 1 h after ischemia. Percent changes 
in pial arteriolar diameter from baseline to 10, 50, and 100 pmol/L NMDA (before versus 1 h 
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after ischemia) were 5±2% versus 3±1%, 20±7% versus 8±2%, and 38±5% versus 19±3%, 
respectively. 
In contrast, in Groups 9-10 we found a dose-dependent preservation of pial vascular 
responses to NMDA. More specifically, in Group 9, baseline arteriolar diameters were 
95±3pm before and 95±4pm 1 h after ischemia. Percent changes in pial arteriolar diameter 
from baseline to 10, 50, and 100 pmol/L NMDA (before versus 1 hr after ischemia) were, 
respectively: 4±0% versus 7±2%, 30±10% versus 23±6%, and 45±6% versus 37±3%. In 
Group 10, baseline arteriolar diameters were 102±6pm before and 106±5pm 1 hr after 
ischemia. Percent changes in pial arteriolar diameter from baseline to 10, 50, and 100 pmol/L 
NMDA (before versus 1 h after ischemia) were, respectively: 7±1% versus 6±2%, 28±5% 
versus 24±4%, and 36±5% versus 32±4%. Therefore, pretreatment with 10 pmol/L DIAZ 
resulted in virtually full preservation of pial arteriolar responses to NMDA 1 h after I/R 
compared to preischemic values. 
Topical application of K A T P antagonist 5-HD, and coapplication of 5-HD with DIAZ 
did not alter pial arteriolar diameters. Also, 5-HD treatment did not affect pial arteriolar 
responses to NMDA (data not shown, see details in Appendix V.). However, pretreatment 
with 5-HD and DIAZ abolished the protection on NMDA-induced vasodilation achieved by 
DIAZ alone. In Group 11, baseline arteriolar diameters were 90±6pm before and 92±6pm 1 h 
after ischemia. Percent changes in pial arteriolar diameter from baseline to 10, 50, and 100 
pmol/L NMDA (before versus 1 h after ischemia) were, respectively: 3±1% versus 0±0%, 
40±12% versus 19±6%, and 61±7% versus 33±5%. Interestingly, coapplication of 5-HD with 
aprikalim did not block the vasodilation elicited by aprikalim (data not shown, see details in 
Appendix EI.). 
Effects of CGRP and papaverine on NMDA-induced vasodilation after H/I 
CGRP and papaverine dilated pial arterioles to similar extent as NS1619 and 
aprikalim. Percent changes from baseline in Group 5 (CGRP) and Group 6 (papaverine) were 
15±4% and 20±2%, respectively. However, pretreatment with either CGRP or papaverine did 
not have protective effect on NMDA-induced vasodilation following H/I, attenuation of the 
response was similar to non-treated controls (Group 2). 
In Group 5, baseline arteriolar diameters were 104±4pm before and 112±7pm 1 h 
after H/I. Percent changes in pial arteriolar diameter from baseline to 10, 50, and 100 pmol/L 
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NMD A (before versus 1 h after H/I) were 6±2% versus 0±0%, 22±5% versus 2±l%, and 
28±7% versus 2±1%, respectively. 
In Group 6, baseline arteriolar diameters were 102±3pm before and 102±2pm 1 h 
after H/I. Percent changes in pial arteriolar diameter from baseline to 10, and 50, pmol/L 
NMDA (before versus 1 h after H/I) were 7±1% versus 3±1%, and 38±4% versus 16±6%, 
respectively. 
Preservation of NMDA-induced vasodilation after I/R by protein synthesis inhibitors 
In normoxic conditions, neither Act-D nor CHX influenced NMDA-induced 
vasodilation significantly in the absence of ischemia. In Group 18, percent changes in pial 
arteriolar diameter from baseline to 10, and 100 pmol/L NMDA (before versus 1 h after Act-
D) were, respectively: 7±3% versus 8±1%, and 37±6% versus 35±4%. Also in Group 18, 
percent changes in pial arteriolar diameter from baseline to 10, and 100 pmol/L NMDA 
(before versus 1 h after CHX) were, respectively: 7±3% versus 5±2%, and 37±6% versus 
30±1%. However, both Act-D and CHX pretreatment resulted in largely (smaller dose), or 
completely (higher dose) preserved pial arteriolar vasodilation to NMDA after I/R. 
Thus, in Group 13 (1 pmol/L Act-D), baseline arteriolar diameters were 98±4pm 
before and 101±5pm 1 h after ischemia. Percent changes in pial arteriolar diameter from 
baseline to 10, and 100 pmol/L NMDA (before versus 1 h after ischemia) were 6±2% versus 
6±2%, and 51±9% versus 39±10%, respectively. 
In Group 14 (10 pmol/L Act-D), baseline arteriolar diameters were 103±lpm before 
and 103±lpm 1 h after ischemia. Percent changes in pial arteriolar diameter from baseline to 
10, and 100 pmol/L NMDA (before versus 1 h after ischemia) were 7±2% versus 7±2%, and 
38±4% versus 35±4% respectively. 
Similarly, in Group 15 (0.3 mg/kg CHX), baseline arteriolar diameters were 110±5pm 
before and 11 l±5pm 1 h after ischemia. Percent changes in pial arteriolar diameter from 
baseline to 10, and 100 pmol/L NMDA (before versus 1 h after ischemia) were 8±2% versus 
8±1%, and 39±4% versus 28±6% respectively. 
Finally, in Group 16 (1 mg/kg CHX), baseline arteriolar diameters were 101±5pm 
before and 99±6pm 1 h after ischemia. Percent changes in pial arteriolar diameter from 
baseline to 10, and 100 pmol/L NMDA (before versus 1 h after ischemia) were 10±2% versus 
6±2%, and 37±7% versus 35±6% respectively. NMDA-induced vasodilation was also 
2 5 
essentially identical to preischemic values in Groups 13-16 at 2 and 4 h after ischemia (data 
not shown, see details in Appendix IV). 
Effect of CHX on hypercapnia-induced vasodilation 
First exposure to graded hypercapnia resulted in a concentration dependent increase in . 
pial arteriolar diameters in accordance with the elevated pC02 levels in all groups of animals. 
In control animals (Group 19, n=5), repeated exposure to high pC02 levels elicited 
essentially identical vasodilation in pial arterioles (Figure 3.). Baseline arteriolar diameters 
were 112±11pm before and 113±llpm 20 min after vehicle (saline) injection. Percent 
changes in pial arteriolar diameter from baseline to 5%, and 10% C0 2 (before versus 20 min 
after treatment) were 21±5% versus 26±5%, and 46±5% versus 44±5% respectively. 
However, in the groups treated with either 0.3 or 1.0 mg/kg CHX iv, vasodilation was 
significantly reduced to either level of hypercapnia (Figure 3). In Group 20 (n=6) baseline 
arteriolar diameters were 102±5pm before and 107±5pm 20 min after CHX treatment. 
Percent changes in pial arteriolar diameter from baseline to 5%, and 10% C0 2 (before versus 
20 min after CHX) were, respectively: 26±5% versus 15±4%, and 42±8% versus 31±6%. 
The attenuation of the response was bigger in the group treated with the higher dose of 
CHX, especially at the lower level of hypercapnia (Figure 3). Thus, in Group 21 (n=8) 
baseline arteriolar diameters were 93±3pm before and 94±5pm 20 min after CHX treatment. 
Percent changes in pial arteriolar diameter from baseline to 5%, and 10% C0 2 (before versus 
20 min after CHX) were 22±2% versus 10±2%, and 49±5% versus 31±3%, respectively. 
Effect of CHX on arterial hypotension-induced vasodilation 
Graded arterial hypotension (25% and 40% reduction in MAP, Grade 1 and Grade 2, 
respectively) resulted in a dose-dependent increase in pial arteriolar diameters in accordance 
with decreased arterial blood pressure levels. In (control) Group 19 (n=5), pial arteriolar 
responses in response to stimulation by arterial hypotension were unaltered (Figure 3). 
Baseline arteriolar diameters were 108±10pm before and 109±8pm 20 min after vehicle. 
Percent changes in pial arteriolar diameter from baseline to hypotension (Grade 1 and Grade 
2, before versus 20 min after vehicle) were 20±4% versus 19±4%, and 31±5% versus 33±4%, 
respectively. 
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Figure 2. Preservation of neuronal-vascular reactivity to 100pmol/L N-methyl-D-aspartate 
(NMDA). Data are expressed as "/«»preservation of arteriolar dilation to NMDA lh after 
treatments with various drugs and physiologic challenges. Thus, 100% means unaltered 
responsiveness to NMDA. 
Cortical depolarization (CD) does not affect NMDA-induced vasodilation (n=9, white bar, 
upper panel). However, 10 min of total global cerebral ischemia followed by reperfusion 
(I/R) significantly decreased arteriolar responses by roughly 50% in both groups receiving I/R 
only (n=8+7, black bars, upper and middle panels). A more severe stress like lOmin severe 
hypoxia immediately followed by 10 min ischemia and then reperfusion (H/I) resulted in even 
greater attenuation (approximately 70%) of NMDA-induced vascular responses (n=7, black 
bar, upper panel). 
Pretreatment with potassium channel openers preserved neuronal-vascular responsiveness to 
NMDA after either anoxic stress, I/R or H/I (gray bars, upper and middle panels). More 
specifically, aprikalim (APK), and NS1619 - selective activators of Ca2+ and ATP-sensitive 
potassium channels ( K A T P K preserved NMDA-induced vasodilation after H/I (n=6, 7, 
respectively; *= significantly different from corresponding untreated H/I control group, 
p<0.05). 
Diazoxide (10 pmol/L, 10DIAZ), per se did not affect NMDA-induced response (n=4, white 
bar, middle panel). However, DIAZ, in a selective dose range (1-10 pmol /L) for 
mitochondrial KATP (mitoKAip) channels, produced dose-dependent preservation of the 
NMDA-induced sequence after I/R (1-10DIAZ+I/R). The highest dose of DIAZ used yielded 
full preservation (n=8,12,12, respectively for 1, 5, and 10 DIAZ, gray bars, middle panel, *= 
significantly different from corresponding untreated I/R control group, p<0.05). This effect 
was blocked by coapplication of DIAZ with 5-hydroxy-decanoate (10 DIAZ/5HD+I/R, n=5,), 
a selective inhibitor of mitoK.ATP channels. 
Pretreatment with other vasodilators like calcitonin gene-related peptide (CGRP) or 
papaverine (PAPVN), was not effective in protecting the response after H/I (n=6, 5, 
respectively, gray bars, upper panel). 
Inhibitors of protein synthesis, the transcription inhibitor Actinomycin-D (10 pmol/L, lOAct-
D), and the translation inhibitor cycloheximide (lmg/kg, 1CHX) did not affect NMDA-
induced vasodilation per se (n=6, 6, respectively, white bars, lower panel. 
However, both doses of Act-D (1, and 10 pmol/L: lAct-D and lOAct-D), and CHX (0.3-1 
mg/kg: .3CHX and 1CHX) employed dose-related preservation of NMDA-induced arteriolar 
responses after I/R (n=5,5,5,5 respectively, gray bars, lower panel, *= significantly different 
from corresponding untreated I/R control group, p<0.05). 
The vasodilator response to arterial hypotension was also largely retained in Group 20 
treated with 0.3 mg/kg CHX (n=6, Figure 3). Baseline arteriolar diameters were 104±3pm 
before and 106±6pm 20 min after CHX. Percent changes in pial arteriolar diameter from 
baseline to hypotension (Grade 1 and Grade 2, before versus 20 min after CHX) were 10±1% 
versus 7±1%, and 21±4% versus 19±4%, respectively. 
However, arteriolar responsiveness to arterial hypotension was severely reduced in the 
animals treated with 1 mg/kg CHX in Group 21 (n=6, Figure 3). Baseline arteriolar diameters 
were 96±3|xm before and 104±12pm 20 min after CHX. Percent changes in pial arteriolar 
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diameter from baseline to hypotension (Grade 1 and Grade 2, before versus 20 min after 
CHX) were 12±3% versus 3±1%, and 26±5% versus 6±4%, respectively. 
However, in Group 21 (n=7) SNP induced dose-dependent pial arteriolar vasodilation 
that was unaffected by treatment with lmg/kg CHX. Baseline arteriolar diameters were 
112±6pm before and 118±7pm 20 min after CHX. Percent changes in pial arteriolar diameter 
from baseline to SNP (1 and 10 pmol/L, before versus 20 min after CHX) were 21 ±4% versus 
19±4%, and 38±5% versus 37±5%, respectively. 
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Figure 3. Effect of CHX treatment on COX-dependent vascular responses. Data are plotted as 
the percent preservation of vascular dilation to arterial hypercapnia and hypotension after 
CHX treatment. 
In the vehicle treated control group pial arteriolar responses to inhalation of 5-10% CO2 
(5%C02 and 10% CO2, respectively) were repeatable and unaltered. Similarly pial arteriolar 
responsiveness to decreased mean arterial pressure by 25 and 40%[Hypotension (Grade 1 and 
Grade 2, respectively)] were also fully preserved. 
In contrast, treatment with 0.3-1 mg/kg CHX significantly reduced vasodilation to both doses 
of hypercapnia (*p<0.05, significantly different from control group). The attenuation of the 
vascular response to arterial hypotension was also elicited by CHX, especially the higher dose 
of CHX almost abolished arteriolar dilation (attenuation -70-80%, *p<0.05, significantly 
different from control group). 
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Effect of CHX on cortical AA metabolism 
In Group 22, topical application of AA onto the brain surface elicited a dose dependent 
increase in the concentrations of PGF2(1 and 6-keto-PGFiu in the aCSF. Repeated application 
of AA resulted in similar changes in aCSF PG levels (Figure 4) CHX attenuated baseline as 
well as AA-stimulated PGF2a levels as soon as 20 minutes following CHX administration. 
Baseline and AA-stimulated (1, 10, and 20 pg/mL) PGF2a concentrations before versus 20 
mm after CHX were 3.94±0.55 versus 1.64±0.42, 5.10±0.76 versus 1.93±0.32, 14.28±3.04 
versus 5.90±1.26 and 14.85±2.00 versus 6.74±1.11 ng/mL (n=9), respectively. The inhibition 
of PGF2a synthesis lasted at least as long as 1 hour after CHX administration (Figure 4). 
Similarly, AA-stimulated 6-keto-PGFla levels were also significantly reduced 20 min after 
administration of CHX. Baseline and AA-stimulated (1, 10, and 20 pg/mL) 6-keto-PGFia 
concentrations before versus 20 min after CHX were 1.74±0.20 versus 1.51±0.37 (not 
significant), 2.29±0.23 versus 1.41±0.29, 5.65±0.60 versus 3.48±0.49 and 6.83±0.77 versus 
3.90±0.48 ng/mL (n=7), respectively. 
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Figure 4. Effect of cycloheximide (CHX) treatment on conversion of exogenous arachidonic 
acid (AA) to PGF2a. Topical application of 1-20 pg/ml AA resulted in concentration-
dependent, reproducible increases in prostaglandinF2a (PGF2a) concentrations in the artificial 
cerebrospinal fluid (control 1 and control 2). In contrast, 20 min after CHX (lmg/kg,) 
treatment, baseline and AA-stimulated PGF2a levels were significantly decreased compared to 
control values. At 1 hr after CHX treatment we obtained similar results, there was a trend 
towards further inhibition of PGF2o synthesis. *p<0.05, significantly different from respective 
control values. 
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Discussion 
The major findings of the studies were the following: 
1 CD does not change pial arteriolar responsiveness to NMD A, and other vasodilatory 
stimuli such as hypercapnia, aprikalim, CGRP, or forskolin. Since neuronal-vascular 
reactivity is unaltered by CD, CD probably does not play a direct role per se in the 
attenuation of NMDA-induced vasodilation after anoxic stress accompanied by anoxic 
CD. 
2 We have shown that activation of K A T P or Kca by selective K C O - s for a short period 
immediately before combined H/I preserves pial arteriolar dilation to NMD A. In 
contrast to the K C O - s , C G R P and papaverine failed to preserve the NMDA vascular 
sequence after H/I. 
3 We demonstrated that the selective mitoKATp opener DIAZ did not directly influence, 
but dose dependently preserved NMDA-induced pial arteriolar vasodilation after I/R 
in piglets. In fact, we presented evidence for the first time showing an in vivo 
protective effect of DIAZ after I/R in the central nervous system 
4 We found that inhibitors of protein synthesis (Act-D and CHX) preserved NMDA-
induced neuronal-vascular sequence after I/R, but they did not directly affect the 
vascular response in normoxic conditions. 
5 We also demonstrated for the first time in vivo that CHX rapidly inhibits COX-activity 
in the piglet cerebral cortex. More specifically, cerebrovascular reactivity to COX-
dependent vasodilatory stimuli like hypercapnia and arterial hypotension were 
diminished within 20 min of CHX administration, but COX-independent vasodilation 
to SNP remained unaffected. Similarly to COX-dependent vascular responses, 
cerebral cortical PG-synthesizing capacity from exogenous AA is largely reduced 
shortly after CHX treatment 
NMDA-induced vasodilation is a complex neuronal-vascular function, and its 
physiological importance in CBF-metabolism coupling is poorly known. However, we 
believe that the findings of these studies yield new important information on the 
pathophysiology of neonatal neuronal injury after ischemic stress. Our approach to assess 
neuronal injury or protection was not based on traditional measures such as recovery of EEG 
activity or determination of infarct size. Rather we established NMDA-induced vasodilation 
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as an assay of short-term changes of neuronal function. NMDA-induced vasodilation can be 
regarded as a prototype of an ischemia-sensitive neuronal-vascular sequence. Preservation of 
this sequence after ischemia must involve spared function of many neurons, those bearing 
functional NMDA receptors, and nNOS+ neurons in mono- or multisynaptic connection with 
the former cells, that need to produce sufficient NO for the pial arteriolar response. 
However, we need to address an important concern: can preservation of NMD A-
receptor function be regarded as neuroprotective? In the last decade, glutamate-induced 
neuronal cell death e.g. excitotoxicity has been widely accepted as a major mechanism of 
cellular injury after anoxic stress. The excitotoxicity concept states that ischemia results in a 
single cascade of events consisting of 1) excessive synaptic glutamate release during I/R, 2) 
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"overexcitation" of ionotropic glutamate receptors permeable to Na and Ca , and 3) 
development of AD, cellular swelling, and intracellular Ca overload culminating in neuronal 
cell death. Three influential discoveries supplied the strongest evidence supporting the 
excitotoxicity hypothesis. 1) Extracellular glutamate increases during ischemia (Benveniste 
et al., 1984). 2) Glutamate receptor antagonists protect cultured neurons against both anoxia 
and glutamate-induced cell death (Rothman, 1984), (3) Glutamate receptor antagonists are 
also neuroprotective in vivo after ischemia (Simon et al., 1984). According to the 
cxcitotoxicity concept, preservation of NMDA receptor function in the reperfusion phase 
would contribute to neuronal injury. 
We believe, however, that the classic excitotoxic concept may not apply to in vivo 
conditions necessarily since it conflicts with convincing experimental data. 1) Increased 
extracellular glutamate levels by glutamate uptake inhibitors do not enhance the development 
of AD in a global ischemia model in rats (Obrenovitch et al., 1998). 2) Also, NMDA receptor 
antagonists MK-801 and 2-amino-phosphonoheptanoate do not delay the development of AD 
(Marranes et al., 1989; Xie et al., 1995). 3) Efficacy of NMDA receptor antagonists to 
prevent neuronal death after I/R may not indicate the specific or unique involvement of these 
ligand-gated cation channels in the pathomechanism of injury. In fact, the neuroprotective 
capacity of different cation channel blockers appears to be redundant and interchangeable to 
some extent. For instance, NMDA receptor antagonists prevent neuronal cultures from injury 
induced by veratridine - a Na+ channel activator (Pauwels et al., 1989). Reciprocally, 
excitotoxic injury was alleviated by voltage-gated Na+ channel antagonist tetrodotoxin in 
hippocampal neurons (Ogure et al, 1988), and also by Ca2+-channel antagonist in cultured 
retinal ganglion cells (Sucher et al., 1991). 
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Therefore, preservation of NMD A receptor activity by no means condemns the 
neurons to die by excitotoxic events. Instead, we believe that preservation of NMDA-induced 
vasodilation indicates: 1) functional protection of an important and complex ligand-gated 
cation channel, and 2) implies less ROS-inflicted cellular damage, and maybe better general 
neuronal viability after anoxic stress. 
KCO-s preserve NMDA-induced vasodilation via actions on plasmolemmal and 
mitochondrial potassium channels 
We observed significant increases in pial arteriolar diameters in response to local 
application of aprikalim and NS1619, indicating that the doses used were effective to induce 
vascular smooth muscle (VSM) hyperpolarization. Thus, the first obvious mechanism of the 
protective effect of these K C O - s was that not the specific activation of K + channels but the 
preischemic hyperemia was protective. This possible mechanism has been rejected based on 
our findings using alternative vasodilatory substances before I/R. Specifically, C G R P and 
papaverine although induced vasodilation comparable to KCO-s, were unable to preserve the 
NMD A vascular sequence after H/I. Interestingly, C G R P elicits vasodilation largely via 
activation of KATP- IN addition, VSM components of NMDA-induced vasodilation are 
resistant to the effects of H/I. In summary, these results indicate that the protective effect of 
K C O - s is independent of their effect on VSM K + channels. Thus, the preserved NMDA-
induced vasodilation must be attributed to actions of K C O - s on neuronal K + channels. 
However, the third K C O , DIAZ was used in a dose that activates the m i toKATp-
channels (1-10 pmol/L). We did not test directly if only m i t o K A T P were activated by DIAZ, 
but fortunately a good indication of selective activation could be the absence of significant 
vasodilation accompanied by drug application. The sarcolemmal potassium channels directly 
mediate the vasodilatory effect of K C O - s on cerebral arterioles. Administration of 5-10 
pmol/L DIAZ elicited only 2-9% arteriolar dilation, and the response was transient, did not 
last for more than 1-2 min. In contrast, we found that the general KATP opener aprikalim (10 
pmol/L) elicits -60-70% increases in vascular diameters, and the vasodilation does not wane. 
Moreover, the dose-dependent effect of DIAZ on preservation of the NMDA-induced 
vasodilation after I/R was inhibited by a selective KATP antagonist 5-HD. 5-HD was found to 
be selective for mitoKATP channels at least in some experimental designs (Garlid et al., 1997; 
Liu et al., 1998; Sato et al., 1998). Also, in our experimental model 5-HD did not inhibit the 
vasodilation induced by aprikalim suggesting minor effects on plasmolemmal KATP channels. 
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These observations, together with those of the literature make us conclude that the protective 
effect of DIAZ on neuronal-vascular function after I/R is most probably mediated by 
activation of mitoKATP-s. The mechanism by which activation of mitoKATP-s may lead to 
increased resistance to I/R remains to be clarified. The duration of global cerebral ischemia 
(10 min) used in the present study has been thought to cause only reversible mitochondrial 
alterations, mitochondria have been shown to recover full function in one-two hours after 
reperfusion (Rechncrona et al., 1979; Sims, 1991). Thus, the attenuation of the NMDA-
mediated cerebral arteriolar response is not likely due to energy failure by inhibited 
mitochondrial function. This notion also supported by the resistance of kainate-induced 
vasodilation to I/R (Bari et al., 1997b). 
All available evidence indicates the involvement of ROS in the attenuation of NMD A-
induced vasodilation, thus reduction of ROS production by KCO-s appears to be a feasible 
mechanism. Based on our findings we believe the protection employed by KCO-s may be 
mediated via 2 different sets of potassium channels, at plasmolemmal and/or mitochondrial 
sites. Activation of plasmolemmal ligand-gated K+ channels (KATp, Kca) results in potassium 
efflux and membrane hyperpolarization approaching the equilibrium potential for potassium. 
Unfortunately, we do not possess direct evidence that could link the activation of K+ channels 
to decreased ROS production in our experimental model. 
However, we do have circumstantial evidence, that the protective effect of KCO-s may 
not be explained simply by their action on the membrane potential. We demonstrated, that 
CD, e.g. loss of membrane potential in the cortical neurons does not attenuate NMDA-
induced vasodilation if cerebral blood flow and metabolism is not compromised. Therefore, 
KCO-s cannot simply preserve responsiveness because the neurons do not depolarize during 
ischemia. Neuronal hyperpolarization by KCO-s may prevent events that are subsequent to 
anoxic depolarization and result in ROS production in the early reperfusion phase. One major 
factor is the accumulation of free cytosolic Ca2+ in the depolarized neurons. The influx of 
Ca through voltage gated channels or ionotropic glutamate receptors may be sufficiently 
• reduced by KCO-s. 
Elevated intracellular Ca2+ levels contribute to ROS production at least through 2 
mechanisms. First, Ca2+ activates phospholipaseA2 that yields AA during ischemia to be 
processed by COX during the reperfusion phase. This mechanism appears to be the most 
important source of extracellularly detected ROS in the piglet (Armstead et al., 1988,1989). 
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Second, cytosolic Ca may enter and accumulate in mitochondria dismpting the electron 
transport chain leading to ROS production as described below in detail. 
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Activation of mitochondrial K A T P channels (mitoKATp) may represent another 
possibility how KCO-s affect intracellular calcium homeostasis. MitoKATP-s have been found 
in the inner membrane of mitochondria (Inoue et al., 1991), and represent a 
pharmacologically distinct population of K A T P (Garlid et al., 1996a). MitoKATP-s appear to 
control the activity of the electron transport chain via regulating mitochondrial matrix volume 
by regulated K+ uptake. In isolated mitochondria, KCO-s induce slight swelling, partially 
dissipate the transmembrane potential (AT, negative inside) but increase the activity of 
electron transport chain, and hence the chemical proton gradient (ApH, alkaline inside); thus 
the total the protonmolive force hardly changes (Garlid, 1996b; Halestrap, 1994; Szewcyk et 
al., 1996; Holmuhamedov et al., 1998). However, Ca2+ uptake depends selectively on AT. 
Mitochondria readily uptake Ca2+ when intracellular levels increase above a so-called 
mitochondrial "buffer" concentration. Ca is transported through the mitochondrial inner 
membrane via the electrogenic Ca2+ uniporter down its electrochemical gradient, thus the rate 
of this transport is solely dependent upon AT (Gunter et al., 1994). Opening of mitoKATP-s 
should decrease mitochondrial Ca2+ uptake by decreasing AT, and KCO-s do induce release 
of Ca2+ from Ca2+-preloaded mitochondria in vitro (Holmuhamedov et al., 1998). 
Mitochondrial Ca2+ overload substantially influences the recovery of mitochondrial function 
following ischemic stress: for example increased mitochondrial Ca2+ sequestration has been 
demonstrated to increase production of ROS (Dykens, 1994; Dugan et al., 1995). In 
conclusion, we carefully hypothesize, that activation of mitoKATP-s by DIAZ may prevent 
mitochondrial overload and subsequent ROS production resulting in preserved NMDA-
induced vasodilation after I/R (Figure). 
Protein synthesis inhibitors preserve NMDA-induced vasodilation by rapid inhibition of 
cyclooxygenase expression 
Attenuation of the NMDA-induced vascular sequence is thought to be elicited by 
ROS-induced alterations of the NMDA receptor positive neurons, or the NMDA receptor 
complex itself (Hoffman et al., 1994; Marro et al., 1998). Recovery of the NMDA-induced 
vascular sequence thus may involve repair and resynthesis of protein structures involved in 
this sequence that are damaged by ROS. Therefore our finding that protein synthesis 
inhibitors Act-D and CHX are preserving this sequence after I/R is somewhat surprising. 
However, we have several reasons to believe that this effect is indeed mediated by specific 
effects of these drugs (Act-D and CHX) on transcription and translation inhibition, 
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respectively. (1) The doses used were proved to be effective in other systems (Pavlik and 
Teisinger, 1980), and (2) the effect on preservation of NMDA-induced vasodilation was dose-
dependent. Further, (3) Act-D and CHX are structurally different and also target different 
sites of protein synthesis. Finally, (4) neither Act-D nor CHX affected NMDA-induced 
vasodilation directly, thus the preservation of this response after I/R is not due to some non-
specific facilitation. 
Similarly to our results of short-term preservation of neuronal-vascular function, other 
studies concluded that pretreatment with protein synthesis inhibitors results in long-term 
protection such as inhibition of delayed cell death in the CA1 region of the hippocampus 
(Goto et al., 1990; Papas et al., 1992), and decreased infarction volume after transient focal 
ischemia (Aronowski et al., 1997; Du et al., 1996). Therefore, selected genes do get 
expressed following H/I that may exaggerate the neuronal damage. Several potential 
neuroprotective mechanisms have been proposed concerning the actions of CHX pretreatment 
in reducing neuronal death after H/I stress. These include (1) CHX-induced mild 
hypothermia, (2) inhibition of apoptosis, and (3) suppression of the postischemic induction of 
an unidentified "noxious/killer protein". The former two possibilities are not feasible in our 
model since (1) mild systemic hypothermia does not preserve NMDA-induced vasodilation 
after I/R (Perciaccante et al., 2000), and (2) the time frame of our experiments is too short to 
develop apoptosis. At present we cannot exclude the rapid postischemic appearance of 
noxious proteins. However, we propose a fourth, previously not considered mechanism, that 
CHX pretreatment would reduce activity of potentially harmful proteins (like COX) during 
the pretreatment period before the onset of ischemic stress. 
Previous evidence strongly indicated the role of COX-derived ROS in the 
pathomechanism of attenuated NMDA-induced vasodilation. COX is thought to be rapidly 
inactivated by self-produced superoxide anions, such that in an active system COX has a half-
life not more than 5-10 min (Egan et al., 1981). This suggests that maintaining active COX 
levels would require continuous de novo enzyme synthesis. These facts offered an attractive 
hypothesis to explain the protective effect of protein synthesis inhibitors on NMDA-induced 
vasodilation after I/R. Namely, protein synthesis inhibitors rapidly decrease bioavailability of 
COX during the pretreatment period resulting in less ROS production during I/R. Ex vivo 
experimental data are in support of this theory, since CHX does inhibit baseline and AA-
stimulated PGE2 and prostacyclin production in brain, spleen and muscle slices obtained from 
rats (Fagan and Goldberg, 1986). CHX also blocked PGF2a production induced by 
interleukin-la in cultured piglet and sheep astrocytes within 20 min (Nam et al., 1995a, 
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1995b). We wanted to test this hypothesis in vivo by assessing COX activity rather than 
quantitative determination of COX protein levels. For instance, immunoblotting of COX after 
CHX treatment would probably have not yielded additional support for this theory. Since 
COX is rapidly inactivated and degraded, functional and immunoreactive COX levels may 
not be equivalent. 
Changes in cortical COX activity after CHX treatment were assessed via 2 
independent techniques: (1) COX-dependent vascular reactivity, and (2) cortical AA 
metabolism. Previous evidence suggests that the prostaglandins required for arteriolar 
vasodilation to hypercapnia and arterial hypotension are synthesized in the vascular 
endothelium (Leffler and Busija, 1987; Leffler et al., 1994a). The presented data suggested, 
that CHX treatment likely affected vascular endothelial cells shown by the attenuation of 
vascular responses to hypercapnia and arterial hypotension. We also found, that 6-keto-
PGF1« levels were reduced in the aCSF after CHX treatment, indicating decreased 
prostacyclin synthesis, further confirming the effect of CHX on cerebrovascular endothelial 
cells. In contrast, the reduced baseline and AA-stimulated PGF2a levels may represent a more 
general inhibitory effect of CHX on COX synthesis in both neural and vascular cells. 
At least 2 distinct isoforms of COX exist (COX-1,-2) (DeWitt, 1991). Originally 
COX-1 was considered the constitutively expressed isoform, and COX-2 was designated as 
the inducible isoform. However, in the brain and cerebral blood vessels of newborn pigs, 
COX-2 but not COX-1 has been identified as the major constitutively expressed isoform (Peri 
et al., 1995; Degi et al., 1998a). COX-2 is an immediate early gene, and is readily inducible 
by a wide variety of stimuli including ischemic stress in piglet cerebral cortex and blood 
vessels (Busija et al., 1996b; Degi et al., 1998b), and in adult brains including gerbils, rats, 
and humans (Ohtsuki et al., 1996; Planas et al. 1995; Sairanen et al., 1998). There is a 
substantial increase in porcine cortical and vascular COX-2 mRNA levels as soon as 2 hrs 
following ischemic stress, and COX-2 immunoreactivity is also increased within 8 hrs of 
cerebral ischemia (Degi et al., 1998b; Domoki et al., 1999). However, the short half-life and 
extremely rapid turnover rate of the COX enzyme may conceal an even more dramatic change 
in COX expression after ischemic stress. The increased expression of COX-2 may participate 
in the brain pathology after ischemic stress by increasing the production of oxygen radicals 
and inflammatory prostanoids. This is an interesting possibility, since overall protein 
synthesis is assumed to be inhibited even by short periods of cerebral ischemia and 
reperfusion (Krause and Tiffany, 1993). However, translation of some other immediate early 
gene mRNA-s including heat shock proteins and proto-oncogenes appear to be increased 
38 
rapidly following ischemic stress in contrast to the generally depressed protein synthesis 
(Koistinaho and Hokfelt, 1997). It is quite conceivable that after cerebral ischemia when 
protein synthesis is generally inhibited, lmg/kg CHX has a greater inhibition on COX 
synthesis than we have shown with the approaches used in our present study under normoxic 
conditions. 
The most likely mechanism of how CHX inhibits COX-activity in our experimental 
model is through its inhibitory effect on translation of proteins. The effect of CHX and other 
protein synthesis inhibitors were found to be proportional to their effect on general protein 
synthesis inhibition (Fagan et al., 1986). In the present study, however, we cannot exclude 
the remote possibility that CHX could affect other proteins as well that may modulate COX-
activity. But the potent, rapid decrease in COX-activity after CHX treatment explains the 
preservation of NMDA-induced vasodilation after I/R. According to our results, preservation 
of the NMDA-induced vascular sequence occurs probably via inhibited ROS production of 
the piglet cerebral cortex by inhibition of COX expression. Our present data thus reveal that 
pretreatment with protein synthesis inhibitors can result in not only inhibiting the appearance 
of a "noxious/killer protein" after ischemia, but also in the rapid disappearance of a 
potentially harmful albeit continuously expressed protein: COX (Figure 5). At present we do 
not know whether this effect of CHX pretreatment may account for the neuroprotection 
observed in other studies. Nevertheless, early events like ROS-induced injury seem to 
determine the fate of brain tissue affected by I/R. 
Summary 
In conclusion, our studies yielded additional evidence that NMDA-induced vasodilation is 
vulnerable to hypoxic/ischemic stress. The mechanism of this injury appears to be principally 
inflicted by ROS, simple depolarization of cortical neurons in the absence of ischemia does 
not affect this unique neuronal-vascular sequence. Therefore, assessment of cerebrovascular 
reactivity to NMDA provides a sensitive assay to investigate ROS-induced acute neuronal 
damage that reflects rather a metabolic than a classical electrophysiological function. We 
were able to demonstrate that specific activators of ligand-gated potassium channels and 
protein synthesis inhibitors preserved NMDA-induced pial arteriolar vasodilation when 
administered prior to I/R. The mechanism of preservation by KCO-s is unknown. However, 
we speculate that the KCO-s act on both plasmolemmal and mitochondrial channels, and the 
principal effect may be the modulation of calcium ion flux between the extracellular space 
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Figure 5. Preservation of N-methyl-D-aspartate (NMDA)-induced pial arteriolar vasodilation 
after ischemia/reperfusion (I/R). NMDA activates neuronal NMDA receptors, and results in 
activation of neuronal nitric oxide (NO) synthase (nNOS) and subsequent NO release, 
diffusion and action on pial arterioles in a multi-step process. Reactive oxygen species (ROS) 
produced by mitochondria and cyclooxygenase (COX) during reperfusion seem to play a 
pivotal role in attenuating the NMDA-induced vasodilation. Both sources of ROS are 
stimulated by increases in cytosolic and mitochondrial Ca2+ concentrations, respectively. 
ROS may target the NMDA receptor complex, yet unknown neuronal processes (?), or NO 
itself via peroxynitrate formation. In accordance with this hypothesis, increased ROS 
elimination by ROS scavengers, or decreased ROS production by cyclooxygenase (COX) 
inhibitor indomethacin, or protein (including COX) synthesis inhibitor cycloheximide shortly 
prior to FR results in preserved vascular responsiveness to NMDA. NMDA-induced dilation 
is also preserved by pretreatment with diazoxide (DIAZ), a selective activator of 
mitochondrial ATP-sensitive potassium channels (mitoKATp), and other K+ channel openers 
(KCO). Activation of mitoKATP may reduce generation of ROS in the reperfusion phase by 
reducing mitochondrial Ca2+ sequestration. Other KCO-s may also activate mitochondrial K+ 
channels or prevent increases in intracellular Ca2+ concentrations by hyperpolarization. 
Reduction in either COX-derived or mitochondrial ROS production appears to be sufficient to 
preserve the vascular response to NMDA after I/R 
4 0 
and the cytosol, as well as the cytosol and mitochondrial matrix. The mechanism how protein 
synthesis inhibition preserved neuronal-vascular responsiveness appears to occur via 
inhibition of COX-derived ROS production. Treatment with CHX that effectively preserved 
NMDA-induced vasodilation also was shown to inhibit COX-activity within the pretreatment 
period similarly to indomethacin. Indeed, according to our knowledge we demonstrated for 
the first time that CHX rapidly inhibits COX-activity in vivo in the cerebral cortex. 
Our results with KCO-s and protein synthesis inhibitors eliciting pharmacological 
preservation of this sequence indicate mechanisms that reduce acute oxidative injury. These 
drugs may also reveal new targets of pharmacotherapy against neuronal injury in neonates. 
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